Medical Condition News

RSS

Beneficial design element in sunitinib phase III clinical trial for gastrointestinal stromal tumors

Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal tumors resistant to the only other available therapy, according to a study in Clinical Cancer Research, a journal of the American Association for Cancer Research.

2 Jun 2012

UH CNRCS students achieve significant milestones in cancer therapy research

Four University of Houston (UH) students are well on their way to emerging cancer research careers upon achieving significant milestones this spring in their work toward new therapies for prostate and breast cancer.

2 Jun 2012

Two pharma companies plan international trials into targeted cancer treatments in the UK

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

2 Jun 2012

'Atzelberg Circle' researchers meet to advance hyperthermia as standard combination cancer therapy

BSD Medical Corporation, a developer and manufacturer of advanced medical systems that utilize heat therapy to treat cancer, announced today that a distinguished, international team of leading oncologists met in council while attending the May 2012 conference of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona, Spain.

2 Jun 2012

Exercise reduces expression of cytokines and alleviates neuropathic pain

Exercise helps to alleviate pain related to nerve damage (neuropathic pain) by reducing levels of certain inflammation-promoting factors, suggests an experimental study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jun 2012

LDK378 compound well-tolerated in patients with ALK+ NSCLC

A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib-the only approved ALK inhibitor. Results of this Novartis-sponsored sudy will be presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology on Sunday, June 3.

2 Jun 2012

New medication proves effective in slowing the spread of metastatic prostate cancer

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.

2 Jun 2012

ENTA announces availability of first non-invasive oral cancer prevention test

Oral cancer is one of the few cancers still on the rise, claiming the lives of as many Americans as melanoma and has shown a recent increase in young, non-smokers. The important news is that oral cancer can now be prevented.

2 Jun 2012

Global cancer rates could go up 75% by 2030, study suggests

"The number of people with cancer is set to surge by more than 75 percent across the world by 2030, with particularly sharp rises in poor countries as they adopt unhealthy 'Westernized' lifestyles," according to a study published Friday in the Lancet, Reuters reports.

2 Jun 2012

MRS, Sectra partner to distribute MRS7 mammography tracking and reporting system

International medical technology company, Sectra, announces an agreement with Mammography Reporting System Inc. (MRS), a leading mammography tracking and reporting system provider, to distribute its solution, MRS7, fully integrated with Sectra Breast Imaging PACS.

2 Jun 2012

First study to correlate dietary fiber intake with inflammatory markers in adolescents

Adolescents who don't eat enough fiber tend to have bigger bellies and higher levels of inflammatory factors in their blood, both major risk factors for cardiovascular disease and diabetes, researchers report.

2 Jun 2012

States taking sides on NYC sugary soda restrictions

A plan by New York City Mayor Michael Bloomberg to limit the sale of large sugary drinks is being met by apprehension by the food industry as other states' leaders consider what example the restrictions could provide for them.

2 Jun 2012

Strong causal link between alcohol consumption and serious palpitations in patients with AF

The term "holiday heart syndrome" was coined in a 1978 study to describe patients with atrial fibrillation who experienced a common and potentially dangerous form of heart palpitation after excessive drinking, which can be common during the winter holiday season. The symptoms usually went away when the revelers stopped drinking. Now, research from UCSF builds on that finding, establishing a stronger causal link between alcohol consumption and serious palpitations in patients with atrial fibrillation, the most common form of arrhythmia.

2 Jun 2012

Lilly launches clinical trial mobile app for oncology healthcare professionals

Today, Eli Lilly and Company launched a searchable clinical trial mobile application for oncology healthcare professionals.

2 Jun 2012

Agendia launches ColoPrint microarray-based 18-gene expression signature for colon cancer

Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.

2 Jun 2012

Study identifies new genetic factor associated with lean diabetes

Type 2 diabetes is popularly associated with obesity and a sedentary lifestyle. However, just as there are obese people without type 2 diabetes, there are lean people with the disease.

2 Jun 2012

Imaging of blood flow provides new way to look into cardiac abnormalities and dysfunction

Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.

2 Jun 2012

HNC patients may be at increased risk for post-treatment side effects

New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.

2 Jun 2012

Study provides novel mechanism of action of anti-cancer compound: perifosine

Aeterna Zentaris Inc. today announced that an article published in the May 2012 issue of Plos One, outlines a novel mechanism of action of the Company's oral anti-cancer compound, perifosine, which could provide a rationale for a novel approach to the treatment of Malignant Pleural Mesothelioma (MMe), an aggressive type of cancer associated with exposure to asbestos.

2 Jun 2012

America's biopharmaceutical researchers work on many new approaches to fight cancer

America's biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America.

2 Jun 2012

Medical Condition News

Beneficial design element in sunitinib phase III clinical trial for gastrointestinal stromal tumors

UH CNRCS students achieve significant milestones in cancer therapy research

Two pharma companies plan international trials into targeted cancer treatments in the UK

'Atzelberg Circle' researchers meet to advance hyperthermia as standard combination cancer therapy

Exercise reduces expression of cytokines and alleviates neuropathic pain

LDK378 compound well-tolerated in patients with ALK+ NSCLC

New medication proves effective in slowing the spread of metastatic prostate cancer

ENTA announces availability of first non-invasive oral cancer prevention test

Global cancer rates could go up 75% by 2030, study suggests

MRS, Sectra partner to distribute MRS7 mammography tracking and reporting system

First study to correlate dietary fiber intake with inflammatory markers in adolescents

States taking sides on NYC sugary soda restrictions

Strong causal link between alcohol consumption and serious palpitations in patients with AF

Lilly launches clinical trial mobile app for oncology healthcare professionals

Agendia launches ColoPrint microarray-based 18-gene expression signature for colon cancer

Study identifies new genetic factor associated with lean diabetes

Imaging of blood flow provides new way to look into cardiac abnormalities and dysfunction

HNC patients may be at increased risk for post-treatment side effects

Study provides novel mechanism of action of anti-cancer compound: perifosine

America's biopharmaceutical researchers work on many new approaches to fight cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News